➥ Serve as an expert and thought leader across the organization and as champion and visionary for process excellence. ➥ Oversee Process Transformation portfolio, strategically guiding enterprise-level optimization.➥ Maximize the value of transformational initiatives through cost-benefit analysis. ➥ Streamline processes and make data-driven decisions to drive enterprise success. ➥ Collaborate cross-functionally to identify improvement opportunities and prioritize efforts for maximum impact. ➥ Drive efficiency, engage employees, and achieve compliance goals through strategic enterprise improvement strategies. ➥ Utilize advanced technology and metrics-driven initiatives to enhance performance. ➥ Foster a culture of process excellence through training and coaching. ➥ Enhance governance, control, and organizational change management practices in partnership with top executives. ➥ Optimize enterprise processes by aligning resources effectively.

➥ Provides day-to-day oversight of R&D and Regulatory operations and oversee global team of 100 employees. ➥ Successfully managed the smooth transition of Elanco's R&D/Regulatory systems and processes during its IPO, surpassing expectations by completing the transition from Lilly Transition Service Agreements on schedule or ahead of time.➥ Secured $50M in capital funding commitments for two major R&D site construction projects in the United States and the European Union, supporting our global growth strategy.➥ Led the integration of the R&D portfolio following the acquisition of Bayer Animal Health, resulting in projected revenues of over $600M (1-3% CAGR) by 2025.➥ Effectively coordinated the merger of Elanco and Bayer Animal Health teams, ensuring seamless operations on Day 1.➥ Established and maintained robust governance and oversight processes for Global Innovation & Regulatory activities.➥ Utilized digital capabilities to enhance the R&D decision-making process, resulting in quicker and more informed decisions.➥ Implemented a strategic restructuring of the R&D and Regulatory organization, achieving a significant reduction in operational expenses by over 25%.➥ Focused on maintaining employee engagement throughout the transition, with successful change management strategies benefiting our 1200 employees.

➥ United Novartis Animal Health and Boehringer Ingelheim employees into the CMC team and Elanco, integrating strengths of each organization including the recruitment, professional development, and retainment of top talent. ➥ Promoted the development of combined culture that welcomes the varied perspectives of Novartis Animal Health and Elanco in order to increase innovation more quickly.➥ Ensured the resolution of technical challenges for 2 key brands (Credelio® and Galliprant®) to launch both brands on time. ➥ Led a 100 person global team to deliver innovation pipeline with high quality and according to global regulations.

➥ Led Global Pharmacovigilance and Promotional Compliance efforts for Elanco's Animal Health portfolio. ➥ Collaborated with regulatory agencies for product safety assurance and adherence to promotional material regulations. ➥ Utilized efficient LEAN and Six Sigma methodologies to optimize performance. ➥ Empowered a trusted and regulated future for animal health.

➥ Oversaw the US Animal Health Surveillance portfolio and maintained close collaboration with CVM/FDA for product safety.➥ Implemented LEAN and Six Sigma practices for enhanced efficiency and to uphold the highest standards of quality and efficacy.

➥ Expertise in LEAN and Six Sigma Techniques. ➥ Proven track record of successfully leading projects through every stage of the pharmaceutical/veterinary health value chain, from discovery to commercialization.

➥ Streamlined global outsourcing of end-to-end product development, from initial discovery to successful commercialization. ➥ Ensured compliance with GLP and GMP regulations. Fostered strong collaborations with leading laboratories and clinical trial facilities.

➥ Lead the HPLC method development and optimization for drug candidates, ensuring precision and efficiency. ➥ Collaborated with diverse teams to establish specifications and secure FDA registration for methods.